Personalis Operating Income 2018-2023 | PSNL
Personalis operating income from 2018 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Personalis Annual Operating Income
(Millions of US $) |
| 2023 |
$-110 |
| 2022 |
$-116 |
| 2021 |
$-65 |
| 2020 |
$-42 |
| 2019 |
$-22 |
| 2018 |
$-14 |
| 2017 |
$-22 |
Personalis Quarterly Operating Income
(Millions of US $) |
| 2023-12-31 |
$-24 |
| 2023-09-30 |
$-31 |
| 2023-06-30 |
$-25 |
| 2023-03-31 |
$-30 |
| 2022-12-31 |
$-32 |
| 2022-09-30 |
$-27 |
| 2022-06-30 |
$-28 |
| 2022-03-31 |
$-28 |
| 2021-12-31 |
$-20 |
| 2021-09-30 |
$-18 |
| 2021-06-30 |
$-15 |
| 2021-03-31 |
$-12 |
| 2020-12-31 |
$-13 |
| 2020-09-30 |
$-10 |
| 2020-06-30 |
$-9 |
| 2020-03-31 |
$-10 |
| 2019-12-31 |
$-7 |
| 2019-09-30 |
$-6 |
| 2019-06-30 |
$-4 |
| 2019-03-31 |
$-5 |
| 2018-12-31 |
|
| 2018-09-30 |
$-2 |
| 2018-06-30 |
$-4 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.074B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
